The role of cxc chemokines as regulators of angiogenesis

Shock

Volumn 4, Issue 3, 1995, Pages 155-160

  Polverini, Peter J ^b   Arenberg, Douglas A ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MICHIGAN SCHOOL OF DENTISTRY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE;

ANGIOGENESIS; ANIMAL; HUMAN; PHYSIOLOGY; REVIEW;

ANIMALS; CHEMOKINES; HUMANS; NEOVASCULARIZATION, PHYSIOLOGIC;

EID: 0029363531     PISSN: 10732322     EISSN: 15400514     Source Type: Journal    
DOI: 10.1097/00024382-199509000-00001     Document Type: Review

References (87)

1. Folkman J, Cotran R: Relation of vascular proliferation to tumor growth. Int Rev Exp Pathol 16:207, 1978.
2. Auerbach R: Angiogenesis-inducing factors: A review. In: Lymphokines. vol. 69. New York, NY: Academic Press, 1981.
3. Polverini, PJ: Macrophage-induced angiogenesis: A review. In: Cytokines. Bazel, Switzerland: S Karger, 1989, pp 54-73.
4. Folkman J: Tumor angiogenesis. Adv Cancer Res 43:175-203, 1985.
5. Folkman J, Klagsbrun M: Angiogenic factors. Science 235:442-447, 1987.
6. Leibovich SJ, Weisman DM: Macrophages, wound repair and angiogenesis. Prog Clin Biol Res 266:131-145, 1988.
7. Engerman RL, Pfaffenenbach D, Davis MD: Cell turnover of capillaries. Lab Invest 17:738-743, 1967.
8. Tannock IF, Hayashi S: The proliferation of capillary and endothelial cells. Cancer Res 32:77-82, 1972.
9. Bouck N: Tumor angiogenesis: Oncogenes and tumor suppressor genes. Cancer Cells 2:179-185, 1990.
10. Eisenstein R, Kuettner KE, Neopolitan C, Sobel LW, Sorgente N: The resistance of certain tissues to invasion. III. Cartilage extracts inhibit the growth of fibroblasts and endothelial cells in culture. Am J Pathol 81: 337-347, 1975.
11. Sorgente N, Kuettner KE, Soble LW, Eisenstein R: The resistance of certain tissues to invasion. II. Evidence for extractable factors in cartilage which inhibit invasion by vascularized mesenchyme. Lab Invest 32:217-222, 1975.
12. Brem H, Folkman J: Inhibition of tumor angiogenesis mediated by cartilage. J Exp Med 141:427-439, 1975.
13. Lee A, Langer R: Shark cartilage contains inhibitors of tumor angiogenesis. Science 221:1185-1187, 1983.
14. Langer R, Conn H, Vacanti J, Haudenschild CC, Folkman J: Control of tumor growth in animals by infusion of an antiangiogenesis inhibitor. Proc Natl Acad Sci USA 77:4331-4335, 1980.
15. Brem S, Preis I, Langer R, Brem H, Folkman J, Patz A: Inhibition of neovascularization by an extract derived from vitreous. Am J Ophthalmol 84:323-328, 1977.
16. Lutty GA, Thompson DC, Gallup JY, Mello RJ, Fenselau A: Vitreous: An inhibitor of retinal extract-induced neovascularization. Inv Ophthalmol Vis Sci 24:52-56, 1983.
17. Madri JA, Pratt BM, Tucker AM: Phenotypic modulation of endothelial cells by transforming growth factor-beta depends upon the composition and organization of the extracellular matrix. J Cell Biol 106:1375-1384, 1988.
18. Ingber DE, Madri JA, Folkman J: A possible mechanism for inhibition of angiogenesis by angiostatic steroids: Induction of capillary basement membrane dissolution. Endocrinology 119:1768-1775, 1986.
19. Ingber DE, Folkman J: Inhibition of angiogenesis through modulation of collagen metabolism. Lab Invest 59:44-51, 1988.
20. Maragoudakis ME, Sarmonika M, Panoutsacopoulou M: Inhibition of basement membrane biosynthesis prevents angiogenesis. J Pharmacol Exp Ther 244:729-733, 1988.
21. Shapiro R, Vallee BL: Human placental ribonuclease inhibitor abolishes both angiogenic and ribonucleolytic activities of angiogenin. Proc Natl Acad Sci USA 84:2238, 1987.
22. Sato N, Fukuda K, Nariuchi H, Sagara N: Tumor necrosis factor inhibits angiogenesis in vitro. J Natl Cancer Inst 79:1383, 1987.
23. Sidky YA, Borden EC: Inhibition of angiogenesis by interferons: Effects on tumor- and lymphocyte-induced vascular responses. Cancer Res 47: 5155-5161, 1987.
24. Peterson, H-I: Tumor angiogenesis inhibition by prostaglandin synthetase inhibitors. Anticancer Res 6:251-254, 1986.
25. Homandberg GA, Kramer-Bjerke J, Grant D, Christiansen G, Eisenstein R: Heparin-binding fragments of fibronectin are potent inhibitors of endothelial cell growth: Structure and function correlates. Biochem Biophys Acta 874:61, 1986.
26. Taylor S, Folkman J: Protamine is an inhibitor of angiogenesis. Nature 297:307-312, 1982.
27. Crum R, Szabo S, Folkman J: A new class of steroids inhibits angiogenesis in the presence of heparin or a heparin fragment. Science 230:1375-1378, 1985.
28. Polverini PJ, Novak RF: Inhibition of angiogenesis by the antineoplastic agents mitoxantrone and bisantrene. Biochem Biophys Res Comm 140: 901-907, 1986.
29. Lee K, Erturk E, Mayer R, Cockett ATK: Efficacy of antitumor chemotherapy in C3H mice enhanced by the antiangiogenesis steroid, cortisone acetate. Cancer Res 47:5021, 1987.
30. Maione TE, Gray GS, Petro J, Hunt AJ, Donner AL, Bauer SI, Carson HF, Sharpe RJ: Inhibition of angiogenesis by recombinant human platelet factor-4. Science 247:77-79, 1990.
31. Rastinejad F, Polverini PJ, Bouck NP: Regulation of the activity of a new inhibitor of angiogenesis by a cancer suppressor gene. Cell 56:345-355, 1989.
32. Good DJ, Polverini PJ, Rastinejad F, LeBeau MM, Lemons RS, Frazier WA, Bouck NP: A tumor suppressor-dependent inhibitor of angiogenesis is immunologically and functionally indistinguishable from a fragment of thrombospondin. Proc Natl Acad Sci USA 87:6624-6628, 1990.
33. Tolsma SS, Volpert OV, Good DJ, Frazier WA, Polverini PJ, Bouck N: Peptides derives from two separate domains of the matrix protein thrombospondin-1 have antiangiogenic activity. J Cell Biol 122:497-511, 1993.
34. O’Reilly MS, Holmgren L, Shing Y, Chen C, Rosenthal RA, Moses M, Lane WS, Cao Y, Sage EH, Folkman J: Angiostatin: A novel angiogenesis inhibitor that mediates the suppression of metastases by Lewis lung cancer carcinoma. Cell 79:315-328, 1994.
35. 3 antagonists promote tumor regression by inducing apoptosis of angiogenic vessels. Cell 79:1157-1164, 1994.
36. Harris ED Jr: Recent insights into the pathogenesis of the proliferative lesion in rheumatoid arthritis. Arthritis Rheum 19:68, 1976.
37. Koch AE, Polverini PJ, Leibovich SJ: Stimulation of neovascularization by human rheumatoid synovial tissue macrophages. Arthritis Rheum 29: 471-479, 1986.
38. Koch AE, Polverini PJ, Kunkel SL, Harlow LA, DiPietro LA, Einer VM, Einer SG, Strieter RM: Interleukin-8 (IL-8) as a macrophage-derived mediator of angiogenesis. Science 258:1798-1801, 1992.
39. Koch AE, Litvak MA, Burrows JC, Polverini PJ: Decreased monocytemediated angiogenesis in scleroderma. Clin Immunol Immunopathol 64: 153-160, 1992.
40. Nickoloff BJ, Mitra RS, Varani J, Dixit VM, Polverini PJ: Aberrant production of interleukin-8 and thrombospondin-1 by psoriatic keratinocytes. Am J Pathol 144:820-828, 1994.
41. Davidson JM: Wound repair. In Gallin JI, Goldstein IM, and Snyderman R (eds): Inflammation: Basic Principles and Clinical Correlates. New York, NY: Raven Press Ltd, 1992.
42. Baggiolini M, Dewald B, Walz A: Interleukin-8 and related chemotactic cytokines. In Gallin JI, Goldstein IM, Snyderman R (eds): Inflammation: Basic Principles and Clinical Correlates. New York, NY: Raven Press Ltd, 1992.
43. Baggiolini M, Walz A, Kunkel SL: Neutrophil-activating peptide-1/ interleukin 8, a novel cytokine that activates neutrophils. J Clin Invest 84:1045-1049, 1989.
44. Matsushima K, Oppenheim JJ: Interleukin 8 and MCAF: Novel inflammatory cytokines inducible by IL-1 and TNF. Cytokine 1:2-13, 1989.
45. Oppenheim JJ, Zachariae OC, Mukaida N, Matsushima K: Properties of the novel proinflammatory supergene “intercrine” cytokine family. Annu Rev Immunol 9:617-648, 1991.
46. Miller MD, Krangel MS: Biology and biochemistry of the chemokines: A family of chemotactic and inflammatory cytokines. Crit Rev Immunol 12:17-46, 1992.
47. Farber JM: HuMIG: A new member of the chemokine family of cytokines. Biochem Biophys Res Comm 192:223-230, 1993.
48. Proost P, De Wolf-Peeters C, Conings R, Opdenakker G, Billiau A, Van Damme J: Identification of a novel granulocyte chemotactic protein (GCP-1) from human tumor cells: In vitro and in vivo comparison with natural forms of GROα, IP-10, and IL-8. J Immunol 150:1000-1010, 1993.
49. Walz A, Burgener R, Car B, Baggiolini M, Kunkel SL, Strieter RM: Structure and neutrophil-activating properties of a novel inflammatory peptide (ENA-78) with homology to IL-8. J Exp Med 174:1355-1362, 1991.
50. Walz A, Baggiolini M: Generation of the neutrophil-activating peptide NAP-2 from platelet basic protein or connective tissue-activating peptide III through monocyte proteases. J Exp Med 171:449-454, 1990.
51. Deutsch E, Kain W: Studies on platelet factor 4. In Jonson SA, Monto RW, Rebuck JW, Horn RC (eds): Blood Platelets. Boston, MA: Little, Brown, 1961, pp 337.
52. Kaplan G, Luster AD, Hancock G, Cohn Z: The expression of a γ interferon-induced protein (IP-10) in delayed immune responses in human skin. J Exp Med 166:1098-1108, 1987.
53. Gusella GL, Musso T, Bosco MC, Espinoza-Delgado I, Matsushima K, Varesio L: IL-2 up-regulates but IFN-γ suppresses IL-8 expression in human monocytes. J Immunol 151:2725-2732, 1993.
54. Schnyder-Candrian S, Strieter RM, Kunkel SL, Walz A: Interferon-α and interferon-γ down-regulate the production of interleukin-8 and ENA-78 in human monocytes. J Leukocyte Biol 1995. In press.
55. Ansiowicz A, Zajchowski D, Stenman G, Sager R: Functional diversity of gro gene expression in human fibroblasts and mammary epithelial cells. Proc Natl Acad Sci USA 85:9645-9649, 1988.
56. Ansiowicz A, Bardwell L, Sager R: Constitutive overexpression of a growth-regulated gene in transformed Chinese hamster and human cells. Proc Natl Acad Sci USA 84:7188-7192, 1987.
57. Richmond A, Thomas HG: Melanoma growth stimulatory activity: Isolation from human melanoma tumors and characterization of tissue distribution. J Cell Biochem 36:185-198, 1988.
58. Yoshimura T, Matsushima K, Oppenheim JJ, Leonard EJ: Neutrophil chemotactic factor produced by LPS-stimulated human blood mononuclear leukocytes: Partial characterization and separation from interleukin- 1. J Immunol 139:788-794, 1987.
59. Matsushima K, Morishita K, Yoshimura T, Lavu S, Obayashi Y, Lew W, Appella E, Kung HF, Leonard EJ, Oppenheim JJ: Molecular cloning of a human monocyte-derived neutrophil chemotactic factor (MDNCF) and the induction of MDNCF mRNA by interleukin-1 and tumor necrosis factor. J Exp Med 167:1883-1893, 1988.
60. Strieter RM, Kunkel SL, Showeil HJ, Marks RM: Monokine-induced gene expression of human endothelial cell-derived neutrophil chemotactic factor. Biochem Biophys Res Commun 156:1340-1345, 1988.
61. Strieter RM, Kunkel SL, Showeil H, Remick DG, Phan SH, Ward PA, Marks RM: Endothelial cell gene expression of a neutrophil chemotactic factor by TNF-α, LPS, and IL-1β. Science 243:1467-1469, 1989.
62. Strieter RM, Phan SH, Showell HJ, Remick DG, Lynch JP, Genard M, Raiford C, Eskandari M, Marks RM, Kunkel SL: Monokine-induced neutrophil chemotactic factor gene expression in human fibroblasts. J Biol Chem 264:10621-10626, 1989.
63. Thornton AJ, Strieter RM, Lindley I, Baggiolini M, Kunkel SL: Cytokineinduced gene expression of a neutrophil chemotactic factor/interleukin-8 by human hepatocytes. J Immunol 144:2609-2613, 1990.
64. Einer VM, Strieter RM, Einer SG, Baggiolini M, Lindley I, Kunkel SL: Neutrophil chemotactic factor (IL-8) gene expression by cytokine-treated retinal pigment epithelial cells. Am J Pathol 136:745-750, 1990.
65. Strieter RM, Chensue SW, Basha MA, Standiford TJ, Lynch JP, Kunkel SL: Human alveolar macrophage gene expression of interleukin-8 by TNFα, LPS and IL-1β. Am J Respir Cell Mol Biol 2:321-326, 1990.
66. Standiford TJ, Kunkel SL, Basha MA, Chensue SW, Lynch JP, Toews GB, Strieter RM: Interleukin-8 gene expression by a pulmonary epithelial cell line: A model for cytokine networks in the lung. J Clin Invest 86:1945-1953, 1990.
67. Strieter RM, Kasahara K, Allen R, Showell HJ, Standiford TJ, Kunkel SL: Human neutrophils exhibit disparate chemotactic factor gene expression. Biochem Biophys Res Comm 173:725-730, 1990.
68. Brown Z, Strieter RM, Chensue SW, Ceska P, Lindley I, Nield GH, Kunkel SL, Westwick J: Cytokine-activated human mesangial cells generate the neutrophil chemoattractant interleukin 8. Kidney Int 40:86-90, 1991.
69. Rolfe MW, Kunkel SL, Standiford TJ, Chensue SW, Allen RM, Evanoff HL, Phan SH, Strieter RM: Pulmonary fibroblast expression of interleukin-8: A model for alveolar macrophage-derived cytokine networking. Am J Respir Cell Mol Biol 5:493-501, 1991.
70. Nickoloff BJ, Karabin GD, Barker JNWN, Giffiths CEM, Sarma V, Mitra RS, Elder JT, Kunkel SL, Dixit VM: Cellular localization of interleukin-8 and its inducer, tumor necrosis factor-alpha in psoriasis. Am J Pathol 138:129-140, 1991.
71. Strieter RM, Kasahara K, Allen RM, Standiford TJ, Rolfe MW, Becker FS, Chensue SW, Kunkel SL: Cytokine-induced neutrophil-derived interleukin-8. Am J Pathol 141:397-407, 1992.
72. Strieter RM, Kunkel SL, Einer VM, Martonyl CL, Koch AE, Polverini PJ, Elner SG: Interleukin-8: A corneal factor that induces neovascularization. Am J Pathol 141:1279-1284, 1992.
73. Hu DE, Hori Y, Fan TPD: Interleukin-8 stimulates angiogenesis in rats. Inflammation 17:135-143, 1993.
74. Sharpe RJ, Byers HR, Scott CF, Bauer SI, Maione TE: Growth inhibition of murine melanoma and human colon carcinoma by recombinant human platelet factor 4. J Natl Cancer Inst 82:848-853, 1990.
75. Maione TE, Gray GS, Hunt AJ, Sharpe RJ: Inhibition of tumor growth in mice by an analogue of platelet factor 4 that lacks affinity for heparin and retains potent angiostatic activity. Cancer Res 51:2077-2083, 1991.
76. Hebert CA, Vitangcol RV, Baker JB: Scanning mutagenesis of interleukin-8 identifies a cluster of residues required for receptor binding. J Biol Chem 266:18989-18994, 1991.
77. Clark-Lewis I, Dewald B, Geiser T, Moser B, Baggiolini M: Platelet factor 4 binds to interleukin 8 receptors and activates neutrophils when its N terminus is modified with Glu-Leu-Arg. Proc Natl Acad Sci USA 90: 3574-3577, 1993.
78. Nickoloff BJ: The cytokine network in psoriasis. Arch Dermatol 127:871-884, 1991.
79. McKay IA, Leigh IM: Epidermal cytokines and their role in cutaneous wound healing. Br J Dermatol 124:513-518, 1991.
80. Symington FW: Lymphotoxin, tumor necrosis factor and gamma interferon are cytostatic for normal human keratinocytes. J Invest Dermatol 92:798-805, 1989.
81. Yaar M, Karassik RL, Schipper LE, Gilchrest BA: Effect of alpha and beta interferon on cultured human keratinocytes. J Invest Dermatol 85:70-74, 1985.
82. Nickoloff BJ, Varani J, Mitra S: Modulation of keratinocyte biology by gamma interferon: Relevance to cutaneous wound healing. In: Clinical Experimental Approaches to Dermal and Epidermal Repair: Normal and Chronic Wounds. New York, NY: Wiley-Liss Inc, 1991, pp 141-154.
83. Nickoloff BJ, Mitra RS: Inhibition of 1251-epidermal growth factor binding to cultured keratinocytes by antiproliferative molecules gamma interferon, cyclosporine A, and transforming growth factor-beta. J Invest Dermatol 93:799-803, 1989.
84. Klagsbrun M, D’Amore M: Regulators of angiogenesis. Annu Rev Physiol 53:217-239, 1991.
85. Pober JS, Cotran RS: Cytokines and endothelial cell biology. Pathol Rev 70:427-451, 1990.
86. Stout AJ, Gresser I, Thompson D: Inhibition of wound healing in mice by local interferon α/β injection. Int J Exp Pathol 74:79-85, 1993.
87. Demaeyer E, Demaeyer-Guignard J: Interferons and other regulatory cytokines. New York, NY: Wiley-Liss Inc, 1988.